Related Experiment Video
Updated: Oct 15, 2025
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.0K
Repetitive Immune-Mediated Noninfectious Endocarditis Necessitating 5 Mitral Valve Replacements
Steven A Muller1, Helen L Leavis2, Karim Taha1
1Department of Cardiology, Division Heart and Lung, University Medical Center Utrecht, Utrecht, the Netherlands.
JACC. Case Reports
|October 25, 2021
Summary
A young patient experienced recurrent noninfectious endocarditis, necessitating five mitral valve replacements. Treatment with Anakinra post-surgery led to sustained stability, offering a potential therapeutic avenue for similar complex cases.
Area of Science:
- Cardiology
- Immunology
- Infectious Diseases
Background:
- Recurrent immune-mediated noninfectious endocarditis poses significant management challenges, often requiring multiple interventions.
- Standard anti-inflammatory treatments, including high-dose prednisone, may not always suffice for severe or refractory cases.
Observation:
- A young patient presented with a history of repeated mitral valve replacements due to persistent immune-mediated endocarditis.
- The patient had undergone five mitral valve replacement surgeries prior to the current management strategy.
Findings:
- Following the fifth mitral valve replacement, the patient was treated with Anakinra, an interleukin-1 receptor antagonist.
- The patient demonstrated sustained clinical stability for 22 months on Anakinra therapy.
Implications:
- Anakinra may represent a viable therapeutic option for managing refractory immune-mediated noninfectious endocarditis, particularly in patients with recurrent valve failure.
- This case highlights the potential of targeted immunomodulatory therapy in complex cardiovascular conditions.
- Further research is warranted to explore the long-term efficacy and safety of Anakinra in similar patient populations.
Keywords:
AnakinraCTD, connective tissue diseaseDacron, polyethylene terephtelateIVIG, intravenous immunoglobulinMV, mitral valveMVR, mitral valve replacementTEE, transesophageal echocardiographyTIA, transient ischemic attackautoimmuneendocarditismitral valve replacementrepetitiveMore Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
44
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
44
01:22Mitral Stenosis I: Introduction
82
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
82
01:18Endocarditis III: Medical Management
45
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
45
01:25Mitral Regurgitation III: Medical Management
51
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
51
01:22Mitral Valve Prolapse II: Assessment and Management
69
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
69
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
45
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
45